BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 26674797)

  • 21. Anti-PLA2R Antibodies in Chinese Patients with Membranous Nephropathy.
    Li X; Wei D; Zhou Z; Wang B; Xu Y; Pan J; Yang C; Lu J; Qiu Y
    Med Sci Monit; 2016 May; 22():1630-6. PubMed ID: 27179439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy.
    Segarra-Medrano A; Jatem-Escalante E; Quiles-Pérez MT; Salcedo MT; Arbós-Via MA; Ostos H; Valtierra N; Carnicer-Cáceres C; Agraz-Pamplona I
    Nefrologia; 2014 May; 34(3):353-9. PubMed ID: 24798555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating anti-phospholipase A2 receptor antibodies as a diagnostic and prognostic marker in Greek patients with idiopathic membranous nephropathy - a retrospective cohort study.
    Provatopoulou S; Kalavrizioti D; Stangou M; Kouri MN; Kalliakmani P; Papasotiriou M; Papachristou E; Goumenos DS; Papagianni A
    Rom J Intern Med; 2019 Jun; 57(2):141-150. PubMed ID: 30864406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum phospholipase A2 receptor antibodies and immunoglobulin G subtypes in adult idiopathic membranous nephropathy: Clinical value assessment.
    Cheng G; Liu J; Gilbert A; Cao Y; An C; Lv Z; Wang C; Nie R; Zhang J; Liu Y; Xia M; Li S; Cai H; Li Y; Li Y; Qin X
    Clin Chim Acta; 2019 Mar; 490():135-141. PubMed ID: 30605630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-Phospholipase A2 Receptor (PLA2R) Antibody and Glomerular PLA2R Expression in Japanese Patients with Membranous Nephropathy.
    Hihara K; Iyoda M; Tachibana S; Iseri K; Saito T; Yamamoto Y; Suzuki T; Wada Y; Matsumoto K; Shibata T
    PLoS One; 2016; 11(6):e0158154. PubMed ID: 27355365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of anti-phospholipasea2-receptor antibodies with clinical course of idiopathic membranous nephropathy.
    Thokhonelidze I; Maglakelidze N; Sarishvili N; Kasradze T; Dalakishvili K
    Georgian Med News; 2015 Apr; (241):49-53. PubMed ID: 25953939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy.
    Hoxha E; Kneißler U; Stege G; Zahner G; Thiele I; Panzer U; Harendza S; Helmchen UM; Stahl RA
    Kidney Int; 2012 Oct; 82(7):797-804. PubMed ID: 22673885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Negative anti-phospholipase A2 receptor antibody status at three months predicts remission in primary membranous nephropathy.
    Stefan G; Stancu S; Zugravu A; Popa O; Zubidat D; Petre N; Mircescu G
    Ren Fail; 2022 Dec; 44(1):258-268. PubMed ID: 35172682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of phospholipase A2 receptor and IgG4 in patients with membranous nephropathy.
    Liu L; Chang B; Wu X; Guo Y; Pan Y; Yang L
    Vasc Health Risk Manag; 2018; 14():103-108. PubMed ID: 29881283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of a phospholipase A2 receptor antibody ELISA in an Australian cohort with membranous glomerulonephritis.
    Ong L; Silvestrini R; Chapman J; Fulcher DA; Lin MW
    Pathology; 2016 Apr; 48(3):242-6. PubMed ID: 27020499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic accuracy of anti-phospholipase A2 receptor (PLA2R) antibodies in idiopathic membranous nephropathy: an Italian experience.
    Porcelli B; Guarnieri A; Ferretti F; Garosi G; Terzuoli L; Cinci F; Tabucchi A; Tampoia M; Abbracciavento L; Villani C; Deleonardi G; Grondona AG; Mazzolini M; La Manna G; Santostefano M; Infantino M; Manfredi M; Spatoliatore G; Rosati A; Somma C; Bizzaro N
    J Nephrol; 2021 Apr; 34(2):573-579. PubMed ID: 33123964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum Antibody and Glomerular Antigen of Antiphospholipase A2 Receptor in Chinese Patients with Idiopathic Membranous Nephropathy.
    Zhang QH; Wu M; Hu ZG; Liu XB; Huang B; Zhang Y; Liu B; Zhu YS; Wang L; Sun ZX
    Biomed Res Int; 2020; 2020():1693710. PubMed ID: 32461964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between the status of phospholipase A2 receptor and prognosis of idiopathic membranous nephropathy.
    Li YQ; Liu ZZ; Lin KX; Liu RH; Ni L; Liu GX; Lan HY; Shi YJ
    Nephrology (Carlton); 2020 Feb; 25(2):144-149. PubMed ID: 31226230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathological features of atypical membranous nephropathy with unknown etiology in adult Chinese patients.
    Jiang Z; Cai M; Dong B; Yan Y; Yang B; Wang M; Wang Y; Li X; Lian L; Li S; Zuo L
    Medicine (Baltimore); 2018 Aug; 97(32):e11608. PubMed ID: 30095619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical value of renal phospholipase A2 receptor deposit in the prognosis evaluation and treatment options of idiopathic membranous nephropathy: A retrospective cohort study.
    Xie Z; Dong W; Li Z; Chen Y; Song L; Li R; Wu Y; Fu L; Liang H; Tao Y; Xie J; Wang W; Liu S; Ye Z; Shi W; Liang X
    Nephrology (Carlton); 2020 Mar; 25(3):219-229. PubMed ID: 31900967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of Glomerular IgG Subclasses Switch in Idiopathic Membranous Nephropathy Classified by Glomerular Phospholipase A2 Receptor Antigen and Serum Antibody.
    Cui HY; Li C; Li H; Wen YB; Duan L; Li Y; Yan XW; Hu YT; Chen LM; Li XM
    Dis Markers; 2021; 2021():9965343. PubMed ID: 34497677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. M-Type Phospholipase A2 Receptor Autoantibody Measured by ELISA has Diagnostic Value in Patients with Idiopathic Membranous Nephropathy.
    Li J; Mulatibieke A; Liu S; Adelibieke Y; Dai C; Chahan S; Chen H
    Clin Lab; 2023 Jun; 69(6):. PubMed ID: 37307127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating antibodies against M-type phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A in Chinese patients with membranous nephropathy.
    Tian C; Li L; Liu T; Qu X; Qiu Y
    Int Urol Nephrol; 2019 Aug; 51(8):1371-1377. PubMed ID: 31227982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anti-phospholipase A2 receptor (anti-PLA2R) antibodies and idiopathic membranous nephropathy: which role in diagnosis and prognosis of this disease?].
    Netti GS; Ranieri E
    G Ital Nefrol; 2014; 31(3):. PubMed ID: 25030016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiphospholipase A2 Receptor Antibody Levels Predict the Risk of Posttransplantation Recurrence of Membranous Nephropathy.
    Quintana LF; Blasco M; Seras M; Pérez NS; López-Hoyos M; Villarroel P; Rodrigo E; Viñas O; Ercilla G; Diekmann F; Gómez-Roman JJ; Fernandez-Fresnedo G; Oppenheimer F; Arias M; Campistol JM
    Transplantation; 2015 Aug; 99(8):1709-14. PubMed ID: 25675198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.